Suxamethonium-induced porcine malignant hyperthermia

Area of Science:

• Anesthesiology and Pharmacology
• Comparative Physiology
• Biochemistry

Background:

• Malignant hyperthermia (MH) is a severe pharmacogenetic disorder of skeletal muscle.
• Halothane is a known trigger for MH, characterized by hypermetabolism and muscle rigidity.
• The response of MH-susceptible individuals to other anesthetic agents requires further elucidation.

Purpose of the Study:

• To compare the metabolic, hemodynamic, and neuroendocrine responses to suxamethonium (SCh) in normal and MH-susceptible swine.
• To contrast the MH triggering potential of SCh with that of halothane.
• To investigate the underlying mechanisms of SCh-induced MH related to calcium regulation.

Main Methods:

• Administered suxamethonium (SCh) to normal and MH-susceptible swine.
• Monitored metabolic parameters (aerobic metabolism, lactate, potassium, hydrogen ion).
• Measured hemodynamic and neuroendocrine (catecholamine) responses.
• Compared results with previously reported data for halothane.

Main Results:

• Suxamethonium induced a faster and more abrupt onset of malignant hyperthermia compared to halothane.
• Maximal changes in aerobic metabolism and body temperature were similar between SCh and halothane.
• SCh elicited smaller increases in lactate, potassium, hydrogen ion, and catecholamine concentrations than halothane.

Conclusions:

• Suxamethonium is a potent trigger for malignant hyperthermia in susceptible swine, with a rapid onset.
• The observed differences in biochemical responses suggest distinct mechanisms for SCh- and halothane-induced MH.
• Dysregulation of intracellular calcium handling, potentially affecting the calcium pump or storage, is implicated in SCh-induced MH.